Onconetix Inc (ONCO) Stock Price, Quote & News

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology

Sector: Healthcare

Phone: 513 620 4101

Website: www.onconetix.com

Address:

201 East Fifth Street, Suite 1900, Cincinnati, United States

Mile111 Aug. 30 at 7:27 PM

$ONCO Not forget people ki Roboter market ITS a billion Dollar Market unitree company IS now billion Dollar worth 🫢🫢🫢💥💥💥💥🔥🔥🔥🔥🔥

0 · Reply

Mile111 Aug. 30 at 3:41 PM

$ONCO uranium you Post all this years why this Not going to 20 Dollar 🤔

1 · Reply

URANIUM77 Aug. 30 at 11:48 AM

$ONCO Cash Position The company has current cash of $34.8M.

0 · Reply

VintageCulture Aug. 29 at 9:10 PM

Watch NCRA 1000% runner potential, 0 shares to short 500% CTB $13 fair value MASSIVE MICRON TIES one of the most undervalued setups you will find 🚨🚨🚨🚨 $LUCY $ONCO $IOTR $YJ

0 · Reply

Mile111 Aug. 28 at 3:52 PM

$ONCO short this pig 🐷

0 · Reply

drweinerdog1 Aug. 28 at 3:47 PM

$ONCO after .60 this scam goes straight to .55

0 · Reply

Adamwys Aug. 28 at 1:00 PM

$ONCO who's going to buy after this RS. or short the shit out this crap

1 · Reply

NotCool Aug. 28 at 2:29 AM

$ONCO another RS. Coming soon. Brought to you by the useless management at ONCO

0 · Reply

URANIUM77 Aug. 27 at 10:07 PM

$ONCO Short squeeze is coming now $PPCB

0 · Reply

Smeagol_the_Trader Aug. 27 at 9:03 PM

$ONCO i think i will take my loss, this is the worse thing i could put my money into+😮‍💨

1 · Reply

Onconetix registers to sell 100M shares of common stock for holders

Aug 13, 2026, 7:00 AM EDT - 17 days ago

Onconetix Quarterly report: Q2 2026

Aug 12, 2026, 8:00 AM EDT - 18 days ago

Onconetix Registration statement: Registration filing

Aug 6, 2026, 8:30 AM EDT - 24 days ago

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Aug 5, 2026, 8:30 AM EDT - 25 days ago

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Jul 7, 2026, 9:00 AM EDT - 7 weeks ago

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Jun 19, 2026, 7:00 PM EDT - 2 months ago

Onco-Innovations Announces Non-Brokered LIFE Offering

Jun 19, 2026, 6:00 PM EDT - 2 months ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Jun 16, 2026, 6:00 PM EDT - 2 months ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Onconetix Registration statement: Registration filing

2026-06-09T10:06:30.000Z - 2 months ago

Onconetix files to sell 100M shares of common stock for holders

2026-05-20T23:50:10.000Z - 3 months ago

Onconetix Inc trading halted, news pending

2026-05-19T12:39:58.000Z - 3 months ago

Onconetix announces 1-for-10 reverse stock split

May 19, 2026, 8:00 AM EDT - 3 months ago

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

2026-05-19T11:47:20.000Z - 3 months ago

Realbotix expects transaction with Onconetix to close by October

May 19, 2026, 7:30 AM EDT - 3 months ago

Realbotix Provides Update on Nasdaq Listing

May 13, 2026, 9:25 AM EDT - 3 months ago

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Onconetix Registration statement: Registration filing

2026-04-28T20:18:54.000Z - 4 months ago

Onconetix files to sell 25M shares of common stock for holders

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Onconetix Registration statement: Registration filing

Apr 9, 2026, 8:30 AM EDT - 5 months ago

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Apr 2, 2026, 8:30 AM EDT - 5 months ago

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

2026-03-31T13:13:26.000Z - 5 months ago

Onconetix CEO Karina Fedasz to step down, David White to succeed

ARTW

Mar 31, 2026, 8:30 AM EDT - 5 months ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Onconetix Proxy statement: Proxy filing

Mar 25, 2026, 12:47 PM EDT - 5 months ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

2026-03-24T23:50:18.000Z - 5 months ago

Onconetix Inc trading halted, news pending

2026-03-23T13:12:26.000Z - 5 months ago

Onconetix announces 1-for-5 reverse stock split

Mar 23, 2026, 8:30 AM EDT - 5 months ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Onconetix Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 6 months ago

Onconetix Annual report: Q4 2025

2026-02-12T13:27:43.000Z - 7 months ago

Onconetix to acquire Realbotix LLC in all-stock transaction

Feb 12, 2026, 8:00 AM EST - 7 months ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 7 months ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Jan 2, 2026, 7:00 AM EST - 8 months ago

Onconetix Proxy statement: Proxy Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 10 months ago

Onconetix Proxy statement: Proxy Filing

2025-11-04T21:45:43.000Z - 10 months ago

Onconetix files to sell 22.07M shares of common stock for holders

Nov 4, 2025, 7:00 AM EST - 10 months ago

Onconetix Registration statement: Registration Filing

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Onconetix Proxy statement: Proxy Filing

Oct 16, 2025, 8:00 AM EDT - 11 months ago

Onconetix Registration statement: Registration Filing

2025-10-16T10:10:38.000Z - 11 months ago

Onconetix files to sell 5.1M shares of common stock for holders

2025-09-26T12:40:45.000Z - 1 year ago

Onconetix announces financing through private placement, debt settlement

VERU

Sep 26, 2025, 8:30 AM EDT - 1 year ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

2025-09-26T12:20:26.000Z - 1 year ago

Onconetix, Ocuvex announce mutual termination of merger agreement

Sep 26, 2025, 8:15 AM EDT - 1 year ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

2025-09-22T12:10:57.000Z - 1 year ago

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

Sep 22, 2025, 8:00 AM EDT - 1 year ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

2025-07-16T12:21:02.000Z - 1 year ago

Onconetix, Ocuvex execute definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 1 year ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

2025-06-16T12:25:20.000Z - 1 year ago

Onconetix receives positive decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 1 year ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

2025-06-12T23:50:23.000Z - 1 year ago

Onconetix Inc trading halted, news pending

Jun 11, 2025, 11:30 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

May 22, 2025, 4:50 PM EDT - 1 year ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 10:00 AM EDT - 1 year ago

Onco-Innovations Uplists to Cboe Canada

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Feb 7, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 11, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Oct 8, 2024, 5:00 AM EDT - 2 years ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Oct 3, 2024, 4:45 PM EDT - 2 years ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 2 years ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Sep 20, 2024, 11:45 AM EDT - 2 years ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 3, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 15, 2024, 6:00 AM EDT - 2 years ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 2 years ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Proxy statement: Proxy Filing

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Jan 21, 2024, 7:00 AM EST - 2 years ago

Onconetix Slides: Corporate presentation

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Nov 2, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 1, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Oct 30, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Issues Letter to Shareholders

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Aug 28, 2023, 4:30 PM EDT - 3 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 3, 2023, 1:02 PM EDT - 3 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Jul 31, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 25, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 17, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 6, 2023, 5:05 PM EDT - 3 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Mile111 Aug. 30 at 7:27 PM

$ONCO Not forget people ki Roboter market ITS a billion Dollar Market unitree company IS now billion Dollar worth 🫢🫢🫢💥💥💥💥🔥🔥🔥🔥🔥

0 · Reply

Mile111 Aug. 30 at 3:41 PM

$ONCO uranium you Post all this years why this Not going to 20 Dollar 🤔

1 · Reply

URANIUM77 Aug. 30 at 11:48 AM

$ONCO Cash Position The company has current cash of $34.8M.

0 · Reply

VintageCulture Aug. 29 at 9:10 PM

Watch NCRA 1000% runner potential, 0 shares to short 500% CTB $13 fair value MASSIVE MICRON TIES one of the most undervalued setups you will find 🚨🚨🚨🚨 $LUCY $ONCO $IOTR $YJ

0 · Reply

Mile111 Aug. 28 at 3:52 PM

$ONCO short this pig 🐷

0 · Reply

drweinerdog1 Aug. 28 at 3:47 PM

$ONCO after .60 this scam goes straight to .55

0 · Reply

Adamwys Aug. 28 at 1:00 PM

$ONCO who's going to buy after this RS. or short the shit out this crap

1 · Reply

NotCool Aug. 28 at 2:29 AM

$ONCO another RS. Coming soon. Brought to you by the useless management at ONCO

0 · Reply

URANIUM77 Aug. 27 at 10:07 PM

$ONCO Short squeeze is coming now $PPCB

0 · Reply

Smeagol_the_Trader Aug. 27 at 9:03 PM

$ONCO i think i will take my loss, this is the worse thing i could put my money into+😮‍💨

1 · Reply

Mile111 Aug. 27 at 6:11 PM

$ONCO 20 or 50 Dollar 🔥?🤔

0 · Reply

Smeagol_the_Trader Aug. 26 at 8:54 PM

$ONCO tired of waiting, i even bought more today!😮‍💨

1 · Reply

Mile111 Aug. 26 at 7:30 PM

$ONCO 10 Dollar 🔥!!!!!!!

1 · Reply

Mile111 Aug. 26 at 7:25 PM

$ONCO this must Go to the Sky 🌟

0 · Reply

URANIUM77 Aug. 26 at 6:59 PM

$ONCO $ONCO — THIS IS A FANTASTIC ENDING AND A MASSIVE OPPORTUNITY FOR US SHAREHOLDERS Onconetix was a tiny biotech. Now it’s becoming a Nasdaq‑listed AI humanoid company. This kind of transformation almost NEVER happens in smallcaps — and when it does, it usually marks the beginning of a major re‑rating. Realbotix is injecting huge value. Humanoid robots are the next mega‑trend. The market is asleep. We’re not. And this is absolutely massive for us ONCO shareholders.

1 · Reply

URANIUM77 Aug. 26 at 6:47 PM

$ONCO 🚀 ONCONETIX x REALBOTIX — THE HUMANOID SUPER‑MERGER THAT THE MARKET IS SLEEPING ON $ONCO Most people have NO idea what this merger actually means. Onconetix didn’t “buy” Realbotix. Realbotix is TAKING OVER Onconetix — and that’s insanely bullish. We’re talking about a company that: 🔥 Builds real humanoid robots with facial expressions, movement, vision, and AI 🔥 Has full U.S. manufacturing already running 🔥 Is delivering 19 humanoids in 2026 with more orders coming 🔥 Owns high‑value patents, IP, hardware + software 🔥 Operates in one of the fastest‑growing markets on the planet 🔥 Now gets a NASDAQ vehicle to scale globally This is NOT dilution. This is a value explosion.

0 · Reply

Blu66 Aug. 26 at 6:37 PM

$ONCO sell Realbotix buy Onco 13500 share price 0.645$ go go

0 · Reply

URANIUM77 Aug. 26 at 6:34 AM

$ONCO Sorry +1300% is correct number

0 · Reply

Lyn30 Aug. 26 at 4:24 AM

$ONCO I bought some knowing the risk . I was checking , to me clearly two scenarios 1) pumps and dilute at multiple steps to keep the value of shareholders 2) dilute and duck shareholders Considering cash and potential less likely number 2 imo. Still who knows

1 · Reply

Lyn30 Aug. 26 at 2:59 AM

$ONCO This thing need to pumpyyy imo

0 · Reply

URANIUM77 Aug. 25 at 10:17 PM

$ONCO The cash amount corresponds to +1,200%.

1 · Reply

URANIUM77 Aug. 25 at 10:12 PM

$ONCO BOOM is coming 👇👇👇💰💰👇👇👇👇👇

0 · Reply

Market Cap	2.42M
Revenue (ttm)	820,000.00
Net Income (ttm)	-14.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,710.98%
Debt to Equity Ratio	0.00

Volume	91,400
Avg Vol	463,102
Day's Range	N/A - N/A
Shares Out	3.95M
Stochastic %K	1%
Beta	2.69
Analysts	Strong Buy
Price Target	N/A